Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / C••• M•••••• C•••••••••

R••••••••• M••••••, an A•••••••• C•••••• P••••••• Portfolio Company, Strengthens its Portfolio of Capabilities through the Acquisition of CP M••••••

Add-on acquisitionclosedadd-onannounced Jun 20, 2024closed Jun 20, 2024Fact
What happened
Target
C••• M•••••• C•••••••••
Platform
R••••••••• M••••••add-on basis: R••••••••• is a portfolio company of A•••••••• C•••••• P••••••• (“A••••••••”), a Washington, D.C.-area private investment firm specializing in government regulated industries.
Control
Control
Share acquired
unknown
Industry
healthcare / medical
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
6 named
Buy side
  • M•••••• L••••••• A•••••Deal partnerconfirmed
    “Matt A•••••, a Managing Partner at A••••••••, said, “R•••••••••’s acquisition of CP M•••••• marks an important milestone for the Company, accelerating R•••••••••’s growth in its core surgical and animal health end-markets.”
  • G••••• A••••••Deal partnerconfirmed
    ““The addition of CP M•••••• aligns seamlessly with R•••••••••’s growth strategy and allows the Company to further its commitment to delivering high-quality surgical solutions”, said G••••• A••••••, a Principal at A••••••••.”
  • R••••••••• M••••••Platformconfirmed
    “R••••••••• is a portfolio company of A•••••••• C•••••• P••••••• (“A••••••••”), a Washington, D.C.-area private investment firm specializing in government regulated industries.”
  • A•••••••• C•••••• P•••••••Sponsorconfirmed
    “R••••••••• is a portfolio company of A•••••••• C•••••• P••••••• (“A••••••••”), a Washington, D.C.-area private investment firm specializing in government regulated industries.”
Advisory side
  • D• A•••••••Buy-side adviserconfirmed
    “D• A••••••• served as financial advisor to R••••••••• M•••••• and A•••••••• on the transaction.”
Side not stated
  • C••• M•••••• C•••••••••Targetconfirmed
    “R••••••••• M•••••• (“R•••••••••” or the “Company”), a leading developer, designer and manufacturer of medical devices focused on advanced surgical fiber and regenerative technologies, announced that it has completed the acquisition of C••• M•••••• C••••••••• (“CP M••••••”).”
Evidence
“R••••••••• M•••••• (“R•••••••••” or the “Company”), a leading developer, designer and manufacturer of medical devices focused on advanced surgical fiber and regenerative technologies, announced that it has completed the acquisition of C••• M•••••• C••••••••• (“CP M••••••”).”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 15, 2026
R••••••••• M••••••, an A•••••••• C•••••• P••••••• Portfolio Company, Strengthens its Portf | Private Equity Intelligence | DFX